Dr. Angelina Tiah is a pioneering biotech scientist and the Founder & Group CEO of 23 Century International Life Science Centre, Southeast Asia’s largest GMP-certified human cell manufacturing facility. A medical graduate from the University of Malaya with dual majors in Chemistry and Biology from Campbell University, USA, Dr. Tiah has redefined regenerative medicine in Asia.
She led the region’s first clinical stem cell study on retinitis pigmentosa, a rare genetic cause of blindness. Her cutting-edge work in developing cell-free secretome therapy—a novel, scalable, and safer alternative to traditional stem cell treatments—has transformed care for conditions like stroke, autism, autoimmune disorders, and chronic wounds. Thousands of patients have benefited from her vision, with published clinical results earning international recognition.
Dr. Tiah’s innovations are reshaping the future of personalized medicine, making her a global thought leader in cellular therapy.
Leave a Reply